Goldman Sachs’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
ACA
CIA
CAI
SIC
KA
Goldman Sachs's IBDX Position: Q2 2026 in Review
Goldman Sachs sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q2 2026, closing a stake of 95,718 shares — an estimated $2.42M sold.
Goldman Sachs first reported a position in IBDX in Q3 2025 and held it in 2 quarters. The position peaked at $2.42M in Q1 2026. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- Goldman Sachs reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
- Goldman Sachs sold 95,718 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $2.42M.
- Goldman Sachs first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and held it in 2 quarters.
- Goldman Sachs's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $2.42M in Q1 2026.
- 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.